IP Library Granted Patent US 10,543,230
Granted Patent B2
US 10,543,230 · App. 15/493,019 · Granted Jan 28, 2020

Redox signaling gel formulation

Inventors: Andrew Hoover (Lehi, UT); James Pack (Park City, UT)
Assignee: RDG HOLDING, INC.
A61K33/20A61K8/042A61K8/19A61K8/20A61K8/25A61K8/8147A61K9/0014A61K9/06A61K33/00A61K33/14A61K47/02C25B1/26A61K2800/48A61K2800/83
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,543,230
App. No.
15/493,019
Granted
Jan 28, 2020
Kind
B2
Abstract

Redox signaling gels are disclosed. Such gels include a composition with at least one reactive oxygen species (ROS) and a rheology modifier. Also presented herein is a process for making the gels which includes making the composition by taking the steps of purifying water to produce ultra-pure water, combining a salt to the ultra-pure water to create a salinated water, electrolyzing the salinated water at a temperature of 4.3 to 5.8° C. such that the electrolyzing is accomplished with an anode, cathode and power source such that the power source comprises a transformer and a rectifier and does not comprise a filter capacitor.

Claims (26)

1. A composition for topical application, comprising:

a rheology modifier and an electrolyzed saline solution formulated as a gel,

the rheology modifier comprising one or more of SiO 2 , MgO, Li 2 O, sodium magnesium silicate, and Na 2 O, and

the electrolyzed saline solution comprising:

sodium at a concentration of 1000 to 1400 ppm,

chloride present at a concentration from 1200 to 1600 ppm, and

hypochlorous acid,

wherein the electrolyzed saline solution further comprises a superoxide radical present at a concentration of 94 μM, wherein at least 95% of the superoxide radical is stable over a 13 month period.

2. The composition of claim 1 , wherein the hypochlorous acid is present at a concentration of about 16 ppm to about 24 ppm or at a concentration of about 2300 ppm to about 2700 ppm.

3. The composition of claim 1 , wherein the electrolyzed saline solution further comprises a hydroxyl radical present at a concentration of 241 μM or a hydroxyl radical present at a concentration of 0 to 10 ppm.

4. The composition of claim 1 , wherein no hydroxyl radical is present in the composition.

5. The composition of claim 1 , wherein the pH of the gel is between 6 and 9.

6. The composition of claim 5 , wherein the pH of the gel is 7.6.

7. The composition of claim 1 , wherein the rheology modifier comprises SiO 2 or sodium magnesium silicate.

8. A method of treating a subject using a composition comprising redox-signaling molecules, the method comprising:

administering the composition of claim 1 to the subject.

9. A method of treating a fungal infection of a subject comprising contacting the fungal infection or an area infected with a fungus with a composition of claim 1 thereby reducing or ameliorating a fungal infection in the subject.

10. A method of reducing the presence of at least one fungus comprising contacting the at least one fungus with a composition of claim 1 , thereby reducing the presence of at least one fungus.

11. The composition of claim 1 , wherein the rheology modifier is present at a concentration of about 1% to about 2% by weight.

12. The composition of claim 1 further comprising a buffering agent.

13. The composition of claim 12 , wherein the buffering agent is present in an amount of about 0.1% to about 5% by weight.

14. The composition of claim 12 , wherein the buffering agent comprises sodium phosphate.

15. The composition of claim 1 , wherein the gel has a viscosity that ranges from about 12,000 centipoise to about 20,000 centipoise.

16. The method of claim 8 , wherein the composition is administered to the subject in an amount of 4 ounces twice daily.

17. The method of claim 9 , wherein the composition is administered to the subject in an amount of 4 ounces twice daily.

18. The method of claim 10 , wherein the composition is administered to the subject in an amount of 4 ounces twice daily.

Assignments (2)
CHANGE OF NAME Recorded Jun 18, 2019
From: REOXCYN DISCOVERIES GROUP, INC.
To: RDG HOLDINGS, INC.
Reel/Frame 049511/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2017
From: HOOVER, ANDREW; PACK, JAMES
To: REOXCYN DISCOVERIES GROUP, INC.
Reel/Frame 042384/0706 →
Continuity (4)
Continuation 14321423 · Jul 1, 2014
Provisional Application 61913803 · Dec 9, 2013
Provisional Application 61887898 · Oct 7, 2013
Related Publication 20170216352A1 · Aug 3, 2017